VIVUS, Inc. Gains 278.87%
Tue 31 Mar 20 at 05:30 PM
VIVUS, Inc. (VVUS:NASDAQ) rocketted at $3.6, representing a gain of 278.9%. The stock got featured on our News Catalysts scanner on Thu 05 Mar 20 at 06:01 PM in the 'EARNINGS' category. From Mon 16 Mar 20, the stock recorded 60.00% Up Days and 18.18% Green Days
The share price of the company has been moving sideways in recent weeks.
About VIVUS, Inc. (VVUS:NASDAQ)
VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.
Top 10 Gainers:
- SG Blocks, Inc. (SGBX:NASDAQ), 351.46%
- VIVUS, Inc. (VVUS:NASDAQ), 278.87%
- Greenland Technologies Holding Corporation (GTEC:NASDAQ), 106.25%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 93.02%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 92.4%
- Rosehill Resources Inc. (ROSE:NASDAQ), 51.85%
- Sanchez Midstream Partners LP (SNMP:NYSEMKT), 43.67%
- Organovo Holdings, Inc. (ONVO:NASDAQ), 43.36%
- PBF Logistics LP (PBFX:NYSE), 43.22%
- ChinaNet Online Holdings, Inc. (CNET:NASDAQ), 37.68%